Evidence map›Paper›PMID 41752783›Full record

ArticleMedicina (Kaunas, Lithuania)2026

Extent of Resection and Survival in IDH-Wildtype Glioblastoma: A Dual-Center Retrospective Study.

Selami Bayram, Mustafa Serkan Alemdar, Ali Murat Tatli, Derya Kivrak Salim, Banu Ozturk, Muharrem Okan Cakir, Mustafa Ozdogan

Abstract readMulticenter Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Medicina (Kaunas, Lithuania), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Selami BayramDepartment of Medical Oncology, Memorial Antalya Hospital, Antalya 07025, Turkey.ORCID 0000-0002-0930-5025
Mustafa Serkan AlemdarDepartment of Medical Oncology, Medical Park Antalya Hospital, Antalya 07160, Turkey.ORCID 0000-0002-7663-6182
Ali Murat TatliDepartment of Medical Oncology, Memorial Antalya Hospital, Antalya 07025, Turkey.
Derya Kivrak SalimDepartment of Medical Oncology, Antalya Training and Research Hospital, Antalya 07100, Turkey.ORCID 0000-0003-4107-3460
Banu OzturkDepartment of Medical Oncology, Antalya Training and Research Hospital, Antalya 07100, Turkey.ORCID 0000-0003-0290-8787
Muharrem Okan CakirSchool of Life Science, Pharmacy and Chemistry, Kingston University, London KT1 2EE, UK.ORCID 0000-0002-9544-8830
Mustafa OzdoganDepartment of Medical Oncology, Memorial Antalya Hospital, Antalya 07025, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Brain NeoplasmsGlioblastomaAdultAgedCohort StudiesFemaleHumansIsocitrate DehydrogenaseKaplan-Meier EstimateMaleMiddle AgedProportional Hazards ModelsRetrospective StudiesIsocitrate Dehydrogenaseextent of resectionGlioblastomagross total resectionIDH-wildtypeMGMT promoter methylationoverall survivalprogression-free survivalStupp protocoltreatment outcome

Identifiers

PMID41752783
PMCPMC12941812

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.